Navigation Links
Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C
Date:11/5/2007

ork days compared with peginterferon alfa-2a, and also achieved statistically and clinically meaningful differences in many of the SF-36 quality-of-life domains."

Key Quality-of-Life Findings from the Phase 2b Study

Working patients in all Albuferon treatment groups recorded fewer days of missed work than was observed in the peginterferon alfa-2a treatment group. All Albuferon groups showed less impairment of health-related quality of life based on SF-36 physical and mental component summary scores.

Significantly fewer working patients taking Albuferon 900 mcg every two weeks reported missing 7 days or more of work during the month prior to their treatment visits at Weeks 12 and 24, vs. patients taking peginterferon alfa- 2a. At week 12, only 4.2% of patients taking Albuferon 900 mcg every two weeks had missed 7 or more days of work the previous month, compared with 18.1% of peginterferon alfa-2a patients (p<.05). At week 24, only 5.3% of Albuferon 900-mcg patients had missed 7 or more days of work the previous month, compared with 20.3% of peginterferon alfa-2a patients (p<.05). At Week 12, working patients taking Albuferon 900-mcg every two weeks reported missing an average of 1.1 days of work during the previous month, while peginterferon alfa-2a patients reported missing an average of 4.3 work days (p<.05). At Week 24, Albuferon 900-mcg patients had missed an average of 1.6 days of work during the previous month, while peginterferon alfa-2a patients had missed an average of 4.7 work days.

At Weeks 12 and 24, the treatment group taking Albuferon 900 mcg every two weeks also reported better scores for all eight SF-36 physical and mental health domains, as well as the physical and mental summary scores, compared with peginterferon alfa-2a. Statistically significant and clinically meaningful differences were observed in the mental health, bodily pain, vitality and social functioning domains. By the Week 12 follow-up visit after the end of tre
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015  Rosa & Co. LLC, a drug development ... today announced its pleasure to be lead partner for ... Systems Pharmacology (QSP). The conference focuses on uses and ... Logo - ... Rosa,s lead sponsorship is the second of ...
(Date:4/28/2015)... , April 28, 2015  BioDelivery Sciences International, ... Sarah DeRossett , MD, PhD to the position ... Affairs.  Dr. DeRossett joins BDSI with nearly twenty-five ... the neurosciences area.  Dr. DeRossett will oversee clinical ... well as the medical support for BDSI,s currently ...
(Date:4/27/2015)... China , April 27, 2015 Techpool Bio-Pharma ... under the leadership of its new chief executive officer, transforming ... Before Henry Lee took office in ... in the pharmaceutical field, including Novartis and Eisai, with more ... China and the Asia-Pacific ...
Breaking Medicine Technology:Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 3BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 2BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 3BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 4Techpool Transforms Into International Player 2Techpool Transforms Into International Player 3
... Jan. 3, 2012 Reportlinker.com announces that ... in its catalogue: Transdermal ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal ...
... 3, 2012  When the FDA removed Fen-Phen from the U.S. ... that powerful diet pills had become a thing of the ... burners sprung up almost immediately, and it wasn,t long before ... bags and medicine cabinets. Demand for these ...
Cached Medicine Technology:Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11BiphedAdrene™, Complex Phenylethylamine Provisional Plus Aggressive Thermogenic Compound, Leads Super-Powerful "Diet Pill" Comeback 2
(Date:4/28/2015)... China (PRWEB) April 28, 2015 Georgia ... major municipalities in China that will partner with the ... reduce smoking in a nation that produces more tobacco ... world. , The project, China Tobacco Control Partnership-Tobacco Free ... leaders have shown willingness to support tobacco control efforts ...
(Date:4/28/2015)... Missouri (PRWEB) April 28, 2015 ... to healthcare executive search, announced today that it has ... & Chief Operating Officer search for The ... , Reporting to QHS President & CEO Arthur ... Officer will have operating responsibility for the Queen’s Medical ...
(Date:4/28/2015)... April 28, 2015 Georgia Partnership ... establishment of telemedicine programs in communities throughout Georgia, announces ... selected as speakers at the American Telemedicine Association ... 2015, in Los Angeles, CA. , GPT’s roster ... Sherrie Williams, Executive Director; Loren Nix, Liaison; and board ...
(Date:4/28/2015)... April 28, 2015 Researchers from four ... dose of a steroid prior to pemetrexed (Alimta) chemotherapy ... reaction. Click here to read the full story ... from the Raabe College of Pharmacy in Ohio, Stanford ... Appalachian Regional Healthcare in Kentucky gave a single dose ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Dead or damaged ... and their property. In many cases, tree removal by a ... way to eliminate the threat. , In their ... of tree removal available to property owners today. Each method ... for a job well done. , The article states that, ...
Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Georgia Partnership for TeleHealth Team Selected to Present at ATA 2015 2Health News:Study Finds New Regimen May Ward Off Skin Rash from Common Mesothelioma Drug, According to Surviving Mesothelioma 2Health News:Tree Removal Methods and Services Discussed in Recent Article by Precision Tree Services 2
... Crestor worked well in those with normal LDL but ... 9 (HealthDay News) -- A widely used cholesterol-lowering drug ... adverse outcomes in people who do not ... Crestor (rosuvastatin), did have high levels of C-reactive protein ...
... LAFAYETTE HILL, Pa., Nov. 9 The NHS Human,Services ... on November,8, 2008 at the Hyatt Regency Penn,s Landing ... for the Foundation, which supports the mission,of NHS Human ... human,services in the country., Every year the Foundation ...
... time to change their Medicare Part D Prescription Drug Coverage begins November ... they so choose, this time period is also an opportunity for people ... , ... Washington (PRWEB) November 9, 2008 -- The National Council on Aging ...
... Glaucoma-related highlights of today,s scientific program of the 2008 ... and European Society of Ophthalmology (SOE) include a study ... carotid artery narrowing and potentially elevated risk for stroke, ... of fasting, common to the world,s seven major religions, ...
... a risk factor for high blood pressure, low levels ... as high levels of sodiumespecially among African Americans, according ... Nephrology,s 41st Annual Meeting and Scientific Exposition in Philadelphia, ... about lowering salt or sodium in the diet in ...
... patients in need of organ transplants on the rise, ... sources for organs. Individuals are willing to donate their ... the poverty rate is high, resulting in numerous reports ... troubling issue will be the topic of a session ...
Cached Medicine News:Health News:Statin Might Help More People Fight Heart Disease Than Thought 2Health News:Statin Might Help More People Fight Heart Disease Than Thought 3Health News:Gala Raises Funds for NHS Human Services 2Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 2Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 3Health News:Attention Seniors: Plans Change. Your Needs Change. Shop and Compare Your Prescription Drug Coverage Now 4Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 2Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 3Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 4Health News:Low potassium linked to high blood pressure 2Health News:Transplant experts convene at ASN Renal Week 2008 to discuss organ trafficking 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: